908 Devices Inc. (MASS)

Market Cap	261.50M
Revenue (ttm)	46.85M
Net Income (ttm)	-33.56M
Shares Out	32.05M
EPS (ttm)	-1.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,969
Open	8.14
Previous Close	8.05
Day's Range	8.05 - 8.15
52-Week Range	6.38 - 26.00
Beta	0.62
Analysts	Buy
Price Target	17.34 (+114.47%)
Earnings Date	May 8, 2023

About MASS

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extra...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 18, 2020
• Employees: 177
• Stock Exchange: NASDAQ
• Ticker Symbol: MASS

Financial Performance

In 2022, 908 Devices's revenue was $46.85 million, an increase of 11.01% compared to the previous year's $42.21 million. Losses were -$33.56 million, 51.4% more than in 2021.

Analyst Forecast

According to 11 analysts, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $17.34, which is an increase of 114.47% from the latest price.

Price Target

$17.34

(114.47% upside)

Analyst Consensus: Buy